Market Cap 27.24M
Revenue (ttm) 640,000.00
Net Income (ttm) -69.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10,921.88%
Debt to Equity Ratio -0.95
Volume 4,825,000
Avg Vol 1,009,246
Day's Range N/A - N/A
Shares Out 30.88M
Stochastic %K 43%
Beta 0.27
Analysts Strong Sell
Price Target $14.60

Company Profile

BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. It also develops its neuroscience candidate, BXCL501, which is an investigational, proprietary, orally...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 475 238 6837
Address:
555 Long Wharf Drive, 12th Floor, New Haven, United States
StockScanners
StockScanners Jul. 15 at 4:54 AM
$BTAI reached 1.17m lets go team be ready for next idea
0 · Reply
StockScanners
StockScanners Jul. 15 at 4:41 AM
$BTAI keep watch if this holds above .99
0 · Reply
TradeX_
TradeX_ Jul. 14 at 7:43 PM
Looks like BMGL might be the next 800% runner. Crazy market! Every micro float ticker has been going parabolic this month. Would not be surprised if they send BMGL up now. BMGL starting to make its move now! Only 750k shares outstanding! 💎 $BTAI $PDC $JBDI $IPST moving
0 · Reply
Stock_Catcher
Stock_Catcher Jul. 14 at 4:52 PM
0 · Reply
topstockalerts
topstockalerts Jul. 14 at 4:46 PM
$BTAI this is holding way too well to ignore
0 · Reply
Oscarca
Oscarca Jul. 14 at 4:40 PM
$BTAI mad swings on this one
0 · Reply
CoffeeRocks
CoffeeRocks Jul. 14 at 4:39 PM
$APUS $BTAI $RGC $VEEE RGC 750$S then split Let’s see 80$ here
1 · Reply
prismmarketview
prismmarketview Jul. 14 at 4:38 PM
PRISM Mid-Day Movers: Fintech and Biotech are Today’s Leaders. AlphaTON Capital Corp. (NASDAQ: $ATON) is moving higher today, with the stock up about 23% to 0.2926 from a prior close of 0.2385. Actuate Therapeutics, Inc. (NASDAQ: $ACTU ) is having another strong session, with the stock up about 17% to 1.76 from a prior close of 1.50. Other Notable Movers: Galectin Therapeutics ( $GALT) up 18% BioXcel Therapeutics ( $BTAI) up 17% Mullen Automotive ( $MULN.X)down -19% https://prismmarketview.com/prism-mid-day-movers-fintech-and-biotech-are-todays-leaders/
0 · Reply
CoffeeRocks
CoffeeRocks Jul. 14 at 4:27 PM
$RGC $BTAI $APUS RGC a runner to 100$ easily
0 · Reply
WenABVEAudit
WenABVEAudit Jul. 14 at 4:26 PM
$BTAI blocked
0 · Reply
Latest News on BTAI
BioXcel Therapeutics reports Q1 EPS (54c), consensus (49c)

2026-05-15T12:03:32.000Z - 2 months ago

BioXcel Therapeutics reports Q1 EPS (54c), consensus (49c)


BioXcel Therapeutics Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 2 months ago

BioXcel Therapeutics Quarterly report: Q1 2026


BioXcel Therapeutics Earnings release: Q1 2026

May 15, 2026, 7:00 AM EDT - 2 months ago

BioXcel Therapeutics Earnings release: Q1 2026


BioXcel Therapeutics Transcript: Investor update

Apr 23, 2026, 2:00 PM EDT - 2 months ago

BioXcel Therapeutics Transcript: Investor update


BioXcel Therapeutics Slides: Investor update

Apr 23, 2026, 2:00 PM EDT - 2 months ago

BioXcel Therapeutics Slides: Investor update


BioXcel Therapeutics enrolls first patients in BXCL501 trial

2026-04-08T11:09:11.000Z - 3 months ago

BioXcel Therapeutics enrolls first patients in BXCL501 trial


BioXcel Therapeutics announces FDA acceptance of Igalmi sNDA

2026-04-01T11:09:26.000Z - 3 months ago

BioXcel Therapeutics announces FDA acceptance of Igalmi sNDA


BioXcel Therapeutics reports Q4 EPS (58c), consensus (63c)

2026-03-27T11:20:13.000Z - 3 months ago

BioXcel Therapeutics reports Q4 EPS (58c), consensus (63c)


BioXcel Therapeutics Annual report: Q4 2025

Mar 27, 2026, 7:00 AM EDT - 3 months ago

BioXcel Therapeutics Annual report: Q4 2025


BioXcel Therapeutics Earnings release: Q4 2025

Mar 27, 2026, 7:00 AM EDT - 3 months ago

BioXcel Therapeutics Earnings release: Q4 2025


BioXcel price target lowered to $6 from $10 at H.C. Wainwright

2026-03-05T13:59:23.000Z - 4 months ago

BioXcel price target lowered to $6 from $10 at H.C. Wainwright


BioXcel Therapeutics Transcript: Status update

Feb 27, 2026, 2:00 PM EST - 4 months ago

BioXcel Therapeutics Transcript: Status update


BioXcel Therapeutics submits sNDA to U.S. FDA for Igalmi

2026-01-20T12:06:39.000Z - 6 months ago

BioXcel Therapeutics submits sNDA to U.S. FDA for Igalmi


BioXcel Therapeutics appoints Pavao as acting CCO

2026-01-12T12:21:09.000Z - 6 months ago

BioXcel Therapeutics appoints Pavao as acting CCO


BioXcel Therapeutics Transcript: AGM 2025

Dec 12, 2025, 9:00 AM EST - 7 months ago

BioXcel Therapeutics Transcript: AGM 2025


BioXcel Therapeutics reports Q3 EPS ($2.18), consensus ($1.34)

2025-11-12T12:16:09.000Z - 8 months ago

BioXcel Therapeutics reports Q3 EPS ($2.18), consensus ($1.34)


BioXcel Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

BioXcel Therapeutics Quarterly report: Q3 2025


BioXcel Therapeutics Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

BioXcel Therapeutics Earnings release: Q3 2025


BioXcel Therapeutics Proxy statement: Proxy Filing

Nov 12, 2025, 7:00 AM EST - 8 months ago

BioXcel Therapeutics Proxy statement: Proxy Filing


BioXcel Therapeutics Proxy statement: Proxy Filing

Oct 31, 2025, 8:00 AM EDT - 9 months ago

BioXcel Therapeutics Proxy statement: Proxy Filing


BioXcel Therapeutics regains compliance with Nasdaq

2025-09-18T11:11:17.000Z - 10 months ago

BioXcel Therapeutics regains compliance with Nasdaq


BioXcel Therapeutics Transcript: Study Result

Sep 10, 2025, 2:00 PM EDT - 10 months ago

BioXcel Therapeutics Transcript: Study Result


BioXcel Therapeutics Press release: Study Result

Sep 10, 2025, 2:00 PM EDT - 10 months ago

BioXcel Therapeutics Press release: Study Result


BioXcel Therapeutics Slides: Study Result

Sep 10, 2025, 2:00 PM EDT - 10 months ago

BioXcel Therapeutics Slides: Study Result


BioXcel Therapeutics Transcript: Study Update

Aug 27, 2025, 8:00 AM EDT - 11 months ago

BioXcel Therapeutics Transcript: Study Update


BioXcel Therapeutics Press release: Study Update

Aug 27, 2025, 8:00 AM EDT - 11 months ago

BioXcel Therapeutics Press release: Study Update


BioXcel Therapeutics Slides: Study Update

Aug 27, 2025, 8:00 AM EDT - 11 months ago

BioXcel Therapeutics Slides: Study Update


BioXcel's agitation drug meets main goal in at-home study

Aug 27, 2025, 7:29 AM EDT - 11 months ago

BioXcel's agitation drug meets main goal in at-home study


BioXcel Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 1 year ago

BioXcel Therapeutics Quarterly report: Q2 2025


BioXcel Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 1 year ago

BioXcel Therapeutics Earnings release: Q2 2025


BioXcel Therapeutics Quarterly report: Q1 2025

May 12, 2025, 7:00 AM EDT - 1 year ago

BioXcel Therapeutics Quarterly report: Q1 2025


BioXcel Therapeutics Earnings release: Q1 2025

May 12, 2025, 7:00 AM EDT - 1 year ago

BioXcel Therapeutics Earnings release: Q1 2025


BioXcel Therapeutics Annual report: Q4 2024

Mar 27, 2025, 10:30 AM EDT - 1 year ago

BioXcel Therapeutics Annual report: Q4 2024


BioXcel Therapeutics Earnings release: Q4 2024

Mar 27, 2025, 10:30 AM EDT - 1 year ago

BioXcel Therapeutics Earnings release: Q4 2024


BioXcel Therapeutics Announces Reverse Stock Split

Feb 6, 2025, 7:00 AM EST - 1 year ago

BioXcel Therapeutics Announces Reverse Stock Split


BioXcel Therapeutics Proxy statement: Proxy Filing

Dec 30, 2024, 7:00 AM EST - 1 year ago

BioXcel Therapeutics Proxy statement: Proxy Filing


BioXcel Therapeutics Proxy statement: Proxy Filing

Dec 18, 2024, 7:00 AM EST - 1 year ago

BioXcel Therapeutics Proxy statement: Proxy Filing


BioXcel Therapeutics Announces Proposed Public Offering

Nov 21, 2024, 4:47 PM EST - 1 year ago

BioXcel Therapeutics Announces Proposed Public Offering


BioXcel Therapeutics Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BioXcel Therapeutics Earnings Call Transcript: Q3 2024


BioXcel Therapeutics Quarterly report: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BioXcel Therapeutics Quarterly report: Q3 2024


BioXcel Therapeutics Earnings release: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BioXcel Therapeutics Earnings release: Q3 2024


BioXcel Therapeutics to Present at ThinkEquity Conference

Oct 29, 2024, 7:00 AM EDT - 1 year ago

BioXcel Therapeutics to Present at ThinkEquity Conference


StockScanners
StockScanners Jul. 15 at 4:54 AM
$BTAI reached 1.17m lets go team be ready for next idea
0 · Reply
StockScanners
StockScanners Jul. 15 at 4:41 AM
$BTAI keep watch if this holds above .99
0 · Reply
TradeX_
TradeX_ Jul. 14 at 7:43 PM
Looks like BMGL might be the next 800% runner. Crazy market! Every micro float ticker has been going parabolic this month. Would not be surprised if they send BMGL up now. BMGL starting to make its move now! Only 750k shares outstanding! 💎 $BTAI $PDC $JBDI $IPST moving
0 · Reply
Stock_Catcher
Stock_Catcher Jul. 14 at 4:52 PM
0 · Reply
topstockalerts
topstockalerts Jul. 14 at 4:46 PM
$BTAI this is holding way too well to ignore
0 · Reply
Oscarca
Oscarca Jul. 14 at 4:40 PM
$BTAI mad swings on this one
0 · Reply
CoffeeRocks
CoffeeRocks Jul. 14 at 4:39 PM
$APUS $BTAI $RGC $VEEE RGC 750$S then split Let’s see 80$ here
1 · Reply
prismmarketview
prismmarketview Jul. 14 at 4:38 PM
PRISM Mid-Day Movers: Fintech and Biotech are Today’s Leaders. AlphaTON Capital Corp. (NASDAQ: $ATON) is moving higher today, with the stock up about 23% to 0.2926 from a prior close of 0.2385. Actuate Therapeutics, Inc. (NASDAQ: $ACTU ) is having another strong session, with the stock up about 17% to 1.76 from a prior close of 1.50. Other Notable Movers: Galectin Therapeutics ( $GALT) up 18% BioXcel Therapeutics ( $BTAI) up 17% Mullen Automotive ( $MULN.X)down -19% https://prismmarketview.com/prism-mid-day-movers-fintech-and-biotech-are-todays-leaders/
0 · Reply
CoffeeRocks
CoffeeRocks Jul. 14 at 4:27 PM
$RGC $BTAI $APUS RGC a runner to 100$ easily
0 · Reply
WenABVEAudit
WenABVEAudit Jul. 14 at 4:26 PM
$BTAI blocked
0 · Reply
Bilipli
Bilipli Jul. 14 at 4:21 PM
$BTAI down fast... still Holding bankruptcy incoming.
0 · Reply
ronahi24
ronahi24 Jul. 14 at 4:14 PM
$BTAI when short covering?
0 · Reply
Babilon1210
Babilon1210 Jul. 14 at 4:12 PM
$BTAI This stock is so stupid
0 · Reply
topstockalerts
topstockalerts Jul. 14 at 4:08 PM
$BTAI anyone else noticing how well this is holding?
0 · Reply
Bilipli
Bilipli Jul. 14 at 4:05 PM
$BTAI seems kast pump dump.. big one is leaving.
0 · Reply
Smsimo
Smsimo Jul. 14 at 4:04 PM
$BTAI should i sell or cut my losses. No idea what happening with this stock right now
0 · Reply
Kingph31
Kingph31 Jul. 14 at 4:03 PM
$BTAI 🔥
0 · Reply
ZXSpectrumNext
ZXSpectrumNext Jul. 14 at 3:50 PM
$BTAI 33% today
0 · Reply
Zardiw
Zardiw Jul. 14 at 3:50 PM
DDAmanda found $NXTC before it ran 225%. This is what early entry looks like. Also found: $HODO $BTAI $BRR Catch the next one: https://DDAmanda.com/
0 · Reply
Reacting_
Reacting_ Jul. 14 at 3:47 PM
$VEEE Insane call man, thanks for making my whole month 🙏🙏 @MomentumZeus deserves a quick Follow, He’s great 🔥🔥 Hope my $BTAI $BNAI $BMNR $NAKA swings run today
0 · Reply
CoffeeRocks
CoffeeRocks Jul. 14 at 3:12 PM
$BTAI $APUS <——- runner 🏃‍♂️
0 · Reply
wndyctyboy1975
wndyctyboy1975 Jul. 14 at 3:09 PM
$BTAI sweet back over a 1.00 come on management get a damn deal done
0 · Reply